#Biotechne
LightNews LightNews
jordanbeckerphd.bsky.social
What I still can't understand is what Thermo, Qiagen, Illumina, Nikon, Zeiss, BD, Biotechne, Abcam, Jax, Sigma [etc] think will happen? How much of common biotech/biomed reagent/instrument company revenue is from universities? Yet silence from them.
February 21, 2025 at 3:30 AM
laurasplan.bsky.social
Thrilled 2b part of the sublime "Viral Behaviors" by the brilliant Roberta Buiani @r0b3r7a.bsky.social exploring cultural, material, artistic significance of viral agents thru across Science, Technology & Arts @bloomsburybooksuk.bsky.social tinyurl.com/bloom-viral-... #sciart #bioart #biotechne
Viral Behaviors
In a new era of global virology that requires novel methodologies to improve the comprehension of viruses and viral phenomena, Viral Behaviors explores the cult…
tinyurl.com
March 3, 2025 at 12:11 PM
labwaste.bsky.social
Vendor swag is getting crazy (I will be completing the whole book)
A stem cell themed activity book from the biotech company biotechne
September 11, 2024 at 2:20 PM
britsocimm.bsky.social
Congratulations to the winner of the 2025 BSI Early Career Research Excellence Award, sponsored by BioTechne, Dr Elena Mitsi @elenamitsi.bsky.social
June 18, 2025 at 7:37 PM
johanduchene.bsky.social
Based on our publication on antibody validation, R&D Biotechne confirmed that MAB4139 and AF6695 exhibit nonspecific binding and have been discontinued. Thanks for that 👍.
For assessing ACKR1 expression, the specific clones 2C3 and 6B7 should be used.
#Metaresearch

www.cell.com/cell-stem-ce...
Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
The atypical chemokine receptor 1 (ACKR1) was discovered on erythrocytes as the Duffy blood group antigen (Cutbush et al., 1950), also called Duffy-antigen/receptor for chemokines, or DARC (Novitzky-B...
www.cell.com
February 6, 2026 at 5:48 PM
mariarrios.bsky.social
I am delighted to finally share a story that we've been developing at the CeTPD in collaboration with TOCRIS biotechne for the last couple of years! 🎉 We're thrilled to introduce BromoCatch a self-labelling tag platform for protein analysis and manipulation.🔬🧫🧪

www.biorxiv.org/content/10.1...
The bromocatch is depicted here. Bromocatch is a small protein that can be fused to a protein of interest and use din combination with a bivalent compound for multiple applications including imaging, biotin-based assays, click conjugation or degradation.
April 8, 2025 at 7:14 PM
sciwhye23.bsky.social
Excited to present this @biotechne #webinar on best practices using #ipscs in #stemcell #research

bit.ly/40n5zxN
Webinar: iPSC Culture and Differentiation Best Practices | Bio-Techne | Bio-Techne
Join this expert-led webinar and discover key techniques for overcoming the challenges of maintaining pluripotency and achieving successful differentiation.
bit.ly
January 21, 2025 at 1:34 AM
carlus-2024.bsky.social
🙏 Merci à @stellaromics et @biotechne / @lunaphore - partenaires clés du Sommet True North Spatial 2026!
👌 PANORAMICS - A Vision INC., fondateur de True North Spatial, est fier de pouvoir compter sur leur soutien!
+infos: www.linkedin.com/feed/update/...
April 17, 2026 at 3:19 PM
carlus-2024.bsky.social
🙏 Thank you to @stellaromics and @biotechne / @lunaphore - key partners of the True North Spatial 2026 Summit!
👌 PANORAMICS - A Vision INC., founder of True North Spatial, is proud to count on their support
+info: www.linkedin.com/feed/update/...
April 17, 2026 at 3:38 PM
profantisles.bsky.social
Come and join us @cardiffuni for a seminar "Exploring New Frontiers with #SpatialBiology" hosted by @nanostringtech & @biotechne
You'll get to hear talks from myself and @GeneFiddler
7th December - registration is free!

engage.bio-techne.com/c09beb
Exploring New Frontiers with Spatial Biology, Cardiff University Symposium
Exploring New Frontiers with Spatial Biology, Cardiff University Symposium
engage.bio-techne.com
December 1, 2023 at 6:50 PM
wernerkeil.bsky.social
#Merck Milliardenübernahme: DAX-Konzern kauft #US Riesen #BioTechne
Großübernahme bei Merck: Unter dem neuen Chef Kai Beckmann kauft der DAX-Konzern für fast 10 Milliarden Euro den US-Laborausrüster Bio-Techne. www.op-online.de/region/darms...
Milliardendeal: Pharmakonzern aus Darmstadt kauft US-Laborausrüster
Großübernahme bei Merck: Unter dem neuen Chef Kai Beckmann kauft der DAX-Konzern für fast 10 Milliarden Euro den US-Laborausrüster Bio-Techne.
www.op-online.de
June 30, 2026 at 10:40 AM
humancellatlas.org
Thank you again to all those who made the #HCA2026GM possible, including our Foundational Sponsor @10xGenomics.bsky.social, our Platinum sponsors Illumina and Roche, and our Gold Sponsors @vizgen.bsky.social and Biotechne Spatial. See all our sponsors and supporters at buff.ly/rKwrd6u
2026 HCA General Meeting - Sponsors
The 2026 Sponsors of the Human Cell Atlas General Meeting.
events.humancellatlas.org
July 7, 2026 at 12:53 PM
pharmaphorum.bsky.social
Germany's #MerckKGaA is poised to increase the size of its life sciences business, which provides tools for #research, #drugdiscovery, and #manufacturing, with an $11.3 billion deal to #acquire US rival #Biotechne.
Merck buys life sciences firm Bio-techne in $11.3bn deal
Merck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne.
buff.ly
June 25, 2026 at 8:30 PM
genomerx.bsky.social
genomirx.com/shop/human-i...
Human IL-2 Alexa Fluor 350-conjugated Antibody @RandD Systems (@biotechne ) @novus @abcam @BioLegend
Human IL-2 Alexa Fluor 350-conjugated Antibody, R&D Systems - GenomiRX
Human IL-2 Alexa Fluor 350-conjugated Antibody
genomirx.com
June 28, 2025 at 8:02 PM
ampath.bsky.social
Which session from Corporate Workshop Day at #AMPath25 was our second-most viewed? None other than biotechne/Asuragen’s “ESR1 Testing and Monitoring in Metastatic Breast Cancer: A Paradigm Shift for Molecular Pathology Labs.”

Watch for free: https://player.vimeo.com/video/1143104921
Microphone on stage at AMP 2025 Annual Meeting promoting free session on ESR1 testing in metastatic breast cancer by Bio-Techne Asuragen.
April 23, 2026 at 3:00 PM
cytokinesociety.bsky.social
If you missed the in-person @biotechne booth which was outside the door of #ilc4 you can still visit virtually #Cytokines2022. Learn about innovative solutions for immune cell activation and cytokine detection.
November 21, 2024 at 6:50 PM
aai.org
Cheers to R&D Systems by @BioTechne for being a key partner at #IMMUNOLOGY2026™! Your presence in Boston helps make this meeting a success. Thank you for fueling the next generation of discovery!
June 3, 2026 at 6:00 PM
humancellatlas.org
We’d really like to thank our Platinum Sponsors Illumina and Roche, and also thank our Gold Sponsors @vizgen.bsky.social and Biotechne Spatial for helping make this #HCA2026GM meeting possible.
June 19, 2026 at 1:17 PM
daphsci.bsky.social
Science folks, it turns out BioTechne compensated it's CEO to the tune of $50 million in 2024 (this includes mostly exercised stock options which he had to enter into arbitration to get). No longer a fan.
July 13, 2025 at 1:18 PM
l2plabs.bsky.social
Slingshot Biosciences Appoints Jim Snook as Senior Vice President, Global Sales
Industry veteran brings extensive life sciences commercial leadership experience from Biotechne, Miltenyi Biotec, and Adaptive Biotechnologies EMERYVILLE, Calif., March 5, 2026 /PRNewswire/ -- Slingshot Biosciences, the pioneer of synthetic cell mimic technology for flow cytometry...
dlvr.it
March 5, 2026 at 2:34 PM
calculito.bsky.social
🔴 William Blair dégrade Bio-Techne après que Merck a mis la main dessus. Pas de drame, juste un petit ajustement qui en dit long sur la confiance dans cette acquisition. Les marchés aiment les certitudes, et là, c'est flou. #BioTechne #mikronews
June 26, 2026 at 8:23 PM
narrowit.bsky.social
Merck KGaA Bio-Techne Deal Puts Life-Science Tools Back in M&A Focus Merck KGaA agreed to acquire Bio-Techne in an $11.3 billion cash transaction...

https://www.narrowit.com/news/merck-kgaa-biotechne-acquisition-life-science-tools-2026-06-25
#MergersAndAcquisitions #MerckKgaa #BioTechne #TECH
Merck KGaA to Acquire Bio-Techne in $11.3 Billion Life-Science Tools Deal | Narrowit.com
Merck KGaA agreed to buy Bio-Techne for $73 per share in cash, valuing the deal at about $11.3 billion.
www.narrowit.com
June 25, 2026 at 4:24 PM